MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

Lai, Ssu-Chuan; Su, Yu-Ting; Chi, Ching-Chi; Kuo, Yung-Che; Lee, Kam-Fai; Wu, Yu-Chih; Lan, Pei-Chi; Yang, Muh-Hwa; Chang, Te-Sheng; Huang, Yen-Hua

doi:10.6084/m9.figshare.11273585.v1

13046_2019_1442_MOESM1_ESM.docx (1.58 MB)

MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

journal contribution

posted on 2019-11-27, 04:40 authored by Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang, Yen-Hua Huang

Additional file 1. Supplementary information.

Funding

Ministry of Science and Technology (VN)

History

Usage metrics

Keywords

Interleukin-6 Phospho-STAT3 OCT4 DNMT3b Drug resistance Hepatocellular carcinoma

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

Funding

Ministry of Science and Technology (VN)

History

Usage metrics

Categories

Keywords

Licence

Exports